Sign In
Buy GEHC
$62.03
+0.0400 (+0.0645%)
At Close: Jun 03, 2026
Unveiling GE HealthCare (GEHC) Q3 Outlook: Wall Street Estimates for Key Metrics
10:21am, Monday, 28'th Oct 2024
Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during
What You Need To Know Ahead of GE HealthCare's Earnings
05:55pm, Thursday, 24'th Oct 2024
GE HealthCare (GEHC) is set to report earnings Wednesday morning, with analysts projecting revenue and profits to rise from the same time last year.
GEHC Stock Declines Despite the Unveiling of CareIntellect Application
02:30pm, Tuesday, 22'nd Oct 2024
GE Healthcare announces CareIntellect for Oncology to provide multi-modal patient data from disparate systems into a single view using generative AI.
GE Vernova Vs. GE Healthcare: Betting On Power Or Medical Tech To Lead AI-Powered Future?
10:09am, Tuesday, 22'nd Oct 2024
Two of GE's high-profile spin-offs, GE Vernova Inc GEV and GE Healthcare Technologies Inc GEHC, are preparing to report their third-quarter earnings, but one seems better positioned for the AI-powered
GE HealthCare announces time-saving AI tool for doctors who treat cancer
12:10pm, Monday, 21'st Oct 2024
GE HealthCare announced a new artificial intelligence application it said will save time for doctors who diagnose and treat cancer. The tool, called CareIntellect for Oncology, can quickly summarize p
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced CareIntellect for Oncology, a new cloud-first application that brings together multi-modal patient data from disparate systems in
GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects
12:10pm, Monday, 21'st Oct 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company. These projects are
MILWAUKEE--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation (CAFF), teamed up to launch a new philanthropic endeavor, Poweri
CHICAGO--(BUSINESS WIRE)--With the aim of increasing access to precision care, GE HealthCare is proud to collaborate with University Medicine Essen (UME) in the establishment of a new Theranostics Cen
GE HealthCare's Shares Rise After the Launch of Versana Premier
12:51pm, Tuesday, 15'th Oct 2024
GEHC launches Versana Premier, an AI-powered ultrasound system with advanced features designed for efficient, high-quality diagnostics across multiple specialties.
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
09:00am, Monday, 14'th Oct 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the new Versana Premier™, the latest release within the Versana ultrasound family of reliable, affordable, easy-t
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
10:40am, Friday, 11'th Oct 2024
GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
11:00am, Thursday, 10'th Oct 2024
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
GE HealthCare to announce third quarter 2024 results on October 30, 2024
08:00am, Tuesday, 08'th Oct 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
02:30am, Monday, 07'th Oct 2024
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent.
